Document is current
Any future updates will be listed below
-
Authors
Alharbi, Wafa Abdulrahman https://orcid.org/0009-0009-1365-0778
Keeler, Johanna https://orcid.org/0000-0002-3905-9857
Benbow, Yasmin https://orcid.org/0009-0006-4129-1918
Vega, Marta Ortega https://orcid.org/0000-0002-2939-650X
Ting, Nicole https://orcid.org/0009-0003-0620-8195
Himmerich, Hubertus https://orcid.org/0000-0003-1209-6073
Treasure, Janet https://orcid.org/0000-0003-0871-4596
- License Information
-
More Information
Article History
Received: 28 October 2025
Accepted: 22 April 2026
First Online: 21 May 2026
Declarations
:
: Hubertus Himmerich, Johanna Louise Keeler, and Janet Treasure report funding from the UK Medical Research Council (MRC) for a double-blinded randomised controlled feasibility trial to test oral ketamine in people with anorexia nervosa and depression. Hubertus Himmerich is the principal investigator of a phase 2 clinical trial investigating the efficacy and safety of investigational COMP360 psilocybin treatment in anorexia nervosa.
